English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

There is significant progress in biomedical sciences to use biomaterials as a potential medium for the delivery of pharmacologically active components to diseased cells. This multidisciplinary approach has established that the therapeutic benefit is not directly proportional to the potency of drugs. It is more related to the mode of drug formulations and routes of administration. Biomaterials play a vital role in the formulations of a wide range of pharmaceutical compounds, including antibodies, peptides, drugs, enzymes, and vaccines. Most of these materials have been engineered to release therapeutics for an extended period to overcome the limitations of conventional therapies. This review has initially discussed a brief history of different biomaterials in drug delivery and the clinical needs of the same. The latter part describes the strategies to use RNA as a therapeutic molecule to stop the synthesis of disease-causing proteins that are generated by the misregulations.

RNA – A choice of potential drug delivery system